FDA Approves Flowonix Maestro Software for Pump Programming
The updated software will begin being implemented this month for use with the Prometra Pump System.
Read More
Phase 3 Results for Baricitinib in Atopic Dermatitis Indicate Efficacy, Safety
Two studies of baricitinib monotherapy for adults with moderate to severe atopic dermatitis met primary efficacy endpoints.
Opioid Prescription at Discharge Linked to Less Follow-up Care
Heart patients discharged from the hospital with an opioid prescription were less likely to participate in planned follow-up care than those without prescribed opioids.
Heart Defects in Newborns Projected to Rise with Climate Change
Exposure to excessive heat, especially during early pregnancy, is expected to drive an increase in congenital heart defects.
Phase 1 Trial of Cannabis Ointment Demonstrates Safety
The ointment, which contains 3% CBD and 3% THC, will be tested for the treatment of psoriasis in an upcoming phase 2 trial.
Methotrexate More Effective In Psoriasis Patients Without Psoriatic Arthritis
The immunosuppressive drug was more effective and resulted in fewer adverse events in patients with psoriasis but without psoriatic arthritis.
USPSTF Reaffirms Prophylactic for Gonococcal Eye Infections in Newborns
The USPSTF continues to recommend universal prophylactic treatment with erythromycin ointment for all newborns.
Intensive Hypertension Treatment Not Shown to Reduce Dementia Risk
The SPRINT MIND study did find that intensive treatment reduced the risk of mild cognitive impairment, a precursor to dementia.
UK Gonorrhea Guideline Guards Against Antibiotic Resistance
Some of the changes come in response to growing concern about antimicrobial resistant strains of gonorrhea.
FDA Designates VentFree Muscle Stimulator a Breakthrough Device
The device is being developed to prevent muscle atrophy and reduce days of ventilator support.
Rituximab Biosimilar Candidate Met Phase 1/3 Endpoints
ABP 798, a biosimilar candidate for rituximab, met pharmacokinetic, efficacy, and safety endpoints in a trial among participants with rheumatoid arthritis.
FDA Approves Fluzone Quadrivalent .5 mL for Children 6-35 Months
This expands the indication of the flu vaccine’s .5 mL dose to this younger age group.
FDA Approves TactiCath Catheter for Atrial Fibrillation
The TactiCath Contact Force Ablation Catheter is used for cardiac ablation procedures.
Madelaine Feldman, MD: New Directions in Rheumatology
Madelaine A. Feldman, MD, touches on new developments in rheumatology including JAK inhibitor research, genetics and epigenetics, and personalized medicine.
Madelaine Feldman, MD: Strategies, Hurdles in Rheumatoid Arthritis Treatment
Madelaine A. Feldman, MD, FACR, shares about the current standard treatment rheumatoid arthritis and the hurdles to providing optimal treatment.
FDA Announces Voluntary Recall for Irbesartan Tablets
The hypertension medication is again being recalled due to carcinogenic impurities.
Dermatologists' Antibiotic Prescribing Habits Have Shifted
Overall antibiotic prescriptions have dropped, but short-term postoperative prescriptions have increased in recent years.
FDA Approves Generic Vigabatrin Tablets
This is the first generic approval of the tablet form of vigabatrin, which is indicated for treating focal seizures in patients with epilepsy.
FDA Fast Tracks Oral Antibiotic for C Difficile Treatment
Currently in phase 1 testing, ACX-362E is being developed as a narrow spectrum antibiotic for the treatment of Clostridium difficile infection.
FDA Approves Device to Treat Heart Defect in Premature Infants
The Amplatzer Piccolo Occluder is implanted via catheter to repair patent ductus arteriosus in newborns weighing as little as 2 pounds.
Video Game Treatment for Kids with Autism, ADHD Suggests Efficacy
A pilot study testing a multi-tasking game in children with autism and ADHD demonstrated feasibility, acceptability, and non-significant efficacy.
Phase 3 Results Show SAGE-217 Treats Postpartum Depression Successfully
Patients treated with SAGE-217 had significantly improved depression scores and were more likely to achieve remission than those receiving placebo.
Minority, Low-Income Students Perceive Barriers to Dermatology Residency
Medical students’ perceptions of the barriers to applying for a dermatology residency vary based on race, ethnicity, and socioeconomic background.
FDA Clears Embrace Epilepsy Smartband for Pediatric Use
The FDA has expanded approval for the Embrace smartband to be used by children aged 6 years and older with epilepsy.
FDA Grants Breakthrough Therapy to Sickle Cell Treatment Crizanlizumab
Crizanlizumab is being developed to prevent painful and unpredictable vaso-occlusive crises in patients with sickle cell disease.
FDA Approves Apadaz sNDA for 2 New Strengths
The FDA has approved 2 new dosages of the pain reliever that combines benzhydrocodone and acetaminophen.
FDA Grants Premarket Approval for WEB Aneurysm Embolization System
The WEB Aneurysm Embolization System is designed to treat intracranial wide neck bifurcation aneurysms.
Advances in HIV Therapies and Comorbidity Research
This past year came with a multitude of new FDA approvals for antiretroviral therapies as well as research highlighting HIV and various comorbidities.
High-Risk Opioid Prescriptions Associated with Hepatic Decompensation
For patients with chronic liver disease, opioid prescriptions are common, and high-risk prescriptions are associated with hepatic decompensation, especially ascites.
SHEA Makes Recommendations for Infection Control in Anesthesiology
The guidance touches on hand hygiene, airway management, environmental disinfection, and IV drug injection recommendations.